• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低成本微流体混合器:它们能胜任这项任务吗?

Low-Cost Microfluidic Mixers: Are They up to the Task?

作者信息

Forrester Jade, Davidson Callum G, Blair May, Donlon Lynn, McLoughlin Daragh M, Obiora Chukwuebuka R, Stockdale Heather, Thomas Ben, Nutman Martina, Brockbank Sarah, Rattray Zahra, Perrie Yvonne

机构信息

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.

Centre for Process Innovation (CPI), Coxon Building, John Walker Rd., Sedgefield, Stockton-on-Tees TS21 3FE, UK.

出版信息

Pharmaceutics. 2025 Apr 25;17(5):566. doi: 10.3390/pharmaceutics17050566.

DOI:10.3390/pharmaceutics17050566
PMID:40430858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12115082/
Abstract

: Microfluidic mixing has become the gold standard procedure for manufacturing nucleic acid lipid-based delivery systems, offering precise control over critical process parameters. The choice and design of microfluidic mixers are often seen as a key driving force affecting the critical quality attributes of the resulting lipid nanoparticles (LNPs). : This study aimed to evaluate LNPs manufactured using two low-cost microfluidic mixers alongside manual mixing (pipette mixing (PM)), followed by characterization studies using orthogonal analytics as well as expression studies to establish whether low-cost microfluidic manufacturing methods are suitable for bench-scale and high-throughput research. : The results show that all manufacturing methods can produce LNPs with sizes ranging between 95 and 215 nm with high encapsulation (70-100%), and enhanced analytics showed variations between the LNPs produced using the different mixers. Despite these differences, pipette mixing production of LNPs demonstrated its application as a high-throughput screening tool for LNPs, effectively distinguishing between different formulations and predicting consistent expression patterns both in vitro and in vivo. : Overall, these results validate the use of low-cost microfluidic mixers without compromising the efficiency and integrity of the resulting LNPs. This study supports the increased accessibility of small-scale LNP manufacturing and high-throughput screening.

摘要

微流控混合已成为制造基于核酸脂质的递送系统的金标准程序,可对关键工艺参数进行精确控制。微流控混合器的选择和设计通常被视为影响所得脂质纳米颗粒(LNP)关键质量属性的关键驱动力。

本研究旨在评估使用两种低成本微流控混合器以及手动混合(移液管混合(PM))制造的LNP,随后进行使用正交分析的表征研究以及表达研究,以确定低成本微流控制造方法是否适用于实验室规模和高通量研究。

结果表明,所有制造方法都可以生产尺寸在95至215纳米之间、具有高封装率(70 - 100%)的LNP,增强分析显示使用不同混合器生产的LNP之间存在差异。尽管存在这些差异,但通过移液管混合生产LNP证明了其作为LNP高通量筛选工具的应用,能够有效区分不同配方并预测体外和体内的一致表达模式。

总体而言,这些结果验证了低成本微流控混合器的使用,同时不影响所得LNP的效率和完整性。本研究支持了小规模LNP制造和高通量筛选的更高可及性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/edc12c06defb/pharmaceutics-17-00566-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/842da3fe696f/pharmaceutics-17-00566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/17c027d29d7d/pharmaceutics-17-00566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/92925227651e/pharmaceutics-17-00566-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/a83db936a6e0/pharmaceutics-17-00566-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/a83996a24b9b/pharmaceutics-17-00566-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/5219dfecf5b1/pharmaceutics-17-00566-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/4b8d253cb055/pharmaceutics-17-00566-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/054ebd4be1d9/pharmaceutics-17-00566-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/fcaddb9bab2b/pharmaceutics-17-00566-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/edc12c06defb/pharmaceutics-17-00566-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/842da3fe696f/pharmaceutics-17-00566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/17c027d29d7d/pharmaceutics-17-00566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/92925227651e/pharmaceutics-17-00566-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/a83db936a6e0/pharmaceutics-17-00566-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/a83996a24b9b/pharmaceutics-17-00566-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/5219dfecf5b1/pharmaceutics-17-00566-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/4b8d253cb055/pharmaceutics-17-00566-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/054ebd4be1d9/pharmaceutics-17-00566-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/fcaddb9bab2b/pharmaceutics-17-00566-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d10/12115082/edc12c06defb/pharmaceutics-17-00566-g010.jpg

相似文献

1
Low-Cost Microfluidic Mixers: Are They up to the Task?低成本微流体混合器:它们能胜任这项任务吗?
Pharmaceutics. 2025 Apr 25;17(5):566. doi: 10.3390/pharmaceutics17050566.
2
Post-encapsulation methods for the preparation of mRNA-LNPs.用于制备mRNA-脂质纳米颗粒的包封后方法。
Drug Deliv Transl Res. 2025 May 6. doi: 10.1007/s13346-025-01866-0.
3
Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.mRNA 脂质纳米粒非冷冻条件下货架期稳定性研究。
Mol Pharm. 2023 Dec 4;20(12):6492-6503. doi: 10.1021/acs.molpharmaceut.3c00956. Epub 2023 Nov 17.
4
Overview on LNP-mRNA encapsulation unit operation: Mixing technologies, scalability, and influence of formulation & process parameters on physico-chemical characteristics.脂质纳米颗粒-信使核糖核酸包封单元操作概述:混合技术、可扩展性以及制剂和工艺参数对物理化学特性的影响。
Int J Pharm. 2025 Mar 15;672:125297. doi: 10.1016/j.ijpharm.2025.125297. Epub 2025 Feb 1.
5
Robust, Scalable Microfluidic Manufacturing of RNA-Lipid Nanoparticles Using Immobilized Antifouling Lubricant Coating.使用固定化防污润滑剂涂层对RNA脂质纳米颗粒进行稳健、可扩展的微流体制备。
ACS Nano. 2025 Jan 14;19(1):1090-1102. doi: 10.1021/acsnano.4c12965. Epub 2024 Dec 19.
6
Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations.非离解脂质和相混合方法对脂质纳米粒制剂结构性质的影响。
Int J Pharm. 2023 Apr 25;637:122874. doi: 10.1016/j.ijpharm.2023.122874. Epub 2023 Mar 21.
7
Characterization of lipid nanoparticles using macro mass photometry: Insights into size and mass.使用宏质量光度法对脂质纳米颗粒进行表征:对尺寸和质量的深入了解。
Anal Chim Acta. 2025 May 15;1351:343944. doi: 10.1016/j.aca.2025.343944. Epub 2025 Mar 15.
8
Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.理解具有混沌微混合器的微流控装置中脂质纳米颗粒的形成机制。
PLoS One. 2017 Nov 28;12(11):e0187962. doi: 10.1371/journal.pone.0187962. eCollection 2017.
9
Understanding the Manufacturing Process of Lipid Nanoparticles for mRNA Delivery Using Machine Learning.利用机器学习理解 mRNA 递释用脂质纳米粒的制造工艺。
Chem Pharm Bull (Tokyo). 2024;72(6):529-539. doi: 10.1248/cpb.c24-00089.
10
Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.通过荧光成像研究核酸从脂质纳米颗粒中逃逸的细胞内运输动力学。
Curr Pharm Biotechnol. 2023 Apr 3. doi: 10.2174/1389201024666230403094238.

本文引用的文献

1
Frit-inlet asymmetric flow field-flow fractionation for the analysis of lipid nanoparticle-protein interactions.用于分析脂质纳米颗粒-蛋白质相互作用的 frit 入口不对称流场-流分级分离法
J Chromatogr A. 2025 Feb 22;1743:465663. doi: 10.1016/j.chroma.2025.465663. Epub 2025 Jan 11.
2
Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective.探索常用可电离脂质和聚乙二醇化脂质对mRNA-脂质纳米颗粒的影响:体外和临床前综合视角
J Control Release. 2025 Jan 10;377:162-173. doi: 10.1016/j.jconrel.2024.11.010. Epub 2024 Nov 18.
3
Tailoring lipid nanoparticle dimensions through manufacturing processes.
通过制造工艺调整脂质纳米颗粒的尺寸。
RSC Pharm. 2024 Sep 23;1(4):841-853. doi: 10.1039/d4pm00128a. eCollection 2024 Oct 15.
4
Synthesizing Lipid Nanoparticles by Turbulent Flow in Confined Impinging Jet Mixers.在受限撞击射流混合器中通过湍流流合成脂质纳米粒子。
J Vis Exp. 2024 Aug 23(210). doi: 10.3791/67047.
5
Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.闪式纳米沉淀辅助可离子化脂质纳米粒自组装用于核酸递送。
Nanoscale. 2024 Apr 4;16(14):6939-6948. doi: 10.1039/d4nr00278d.
6
A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient.仔细观察脂质纳米颗粒的特征:分析用于包裹 RNA 货物大小梯度的基准制剂。
Sci Rep. 2024 Jan 29;14(1):2403. doi: 10.1038/s41598-024-52685-1.
7
Antisolvent fabrication of monodisperse liposomes using novel ultrasonic microreactors: Process optimization, performance comparison and intensification effect.采用新型超声微反应器反溶剂法制备单分散脂质体:过程优化、性能比较和强化效果。
Ultrason Sonochem. 2024 Feb;103:106769. doi: 10.1016/j.ultsonch.2024.106769. Epub 2024 Jan 17.
8
Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development.用于药物/基因递送的脂质纳米颗粒:生产技术概述及其产业化发展中遇到的困难
ACS Mater Au. 2023 Aug 21;3(6):600-619. doi: 10.1021/acsmaterialsau.3c00032. eCollection 2023 Nov 8.
9
The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism.脂质纳米粒的配方混合方法会影响 mRNA 的递送效果和器官趋向性。
Eur J Pharm Biopharm. 2023 Nov;192:126-135. doi: 10.1016/j.ejpb.2023.10.006. Epub 2023 Oct 12.
10
Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations.非离解脂质和相混合方法对脂质纳米粒制剂结构性质的影响。
Int J Pharm. 2023 Apr 25;637:122874. doi: 10.1016/j.ijpharm.2023.122874. Epub 2023 Mar 21.